IPO

GPT Healthcare Limited IPO

Mainboard

Hospital

Listed On: Feb 29, 2024 at ₹ 215.0(NSE)

₹ 14880 /80 Shares

Check Allotment

22 Feb, 2024

Open Date

26 Feb, 2024

Close Date

27 Feb, 2024

Allotment Date

29 Feb, 2024

Listing Date
Price Summary

Last Closing

136.00 (-26.88%)

52 Week High

191.05

52 Week Low

126.10

Last Update

18-Dec-2025 3:30 PM
GPT Healthcare Limited IPO Issue Details
  • Issue Price ₹177-186 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 2,82,33,323 shares(aggregating up to ₹525.14 crore)
  • Fresh Share 21,50,537 shares(aggregating up to ₹40 crore)
  • Offer For Sale 2,60,82,786 shares(aggregating up to ₹485.14 crore)
  • Listing at BSE, NSE
  • List Price 215.0(NSE)
  • Listing Date 2024-02-29
  • Lead Manager Jm Financial Limited
  • Registrar Link Intime India Private Ltd
Market Lot Size

Investors can bid for a minimum of 80 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (min) 1 80 ₹14,880
Retail(max) 13 1040 ₹1,93,440
SHNI(min) 14 1120 ₹2,08,320
SHNI(max) 67 5360 ₹9,96,960
BHNI(min) 68 5440 ₹10,11,840
GPT Healthcare Limited IPO Reservation

GPT Healthcare Limited IPO offers total 28,233,323 shares. Out of which 5,646,665 (20%) allocated to QIB, 4,234,999 (15%) allocated to NII,9,881,663 (35%) allocated to RII, NA (NA%) allocated to employees and 8,469,996 (30%) allocated to Anchor investors.

Investor Category Shares Offered Maximum Allottees
Anchor Investor Shares Offered 8,469,996 (30%)
QIB Shares Offered 5,646,665 (20%)
NII (HNI) Shares Offered 4,234,999 (15%)
bNII > ₹10L 2,823,333 (10%)
sNII < ₹10L 1,411,667 (5%)
Retail Shares Offered 9,881,663 (35%)
Total Shares Offered 28,233,323 (100%)
GPT Healthcare Limited IPO Documents
GPT Healthcare Limited IPO Details


GPT Healthcare Limited IPO is a book-built issue of ₹525.14 crores, The total issue size is ₹525.14 crores. The IPO of GPT Healthcare Limited is priced at ₹177-186 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Feb 22, 2024 and ends on Feb 26, 2024. The allotment for GPT Healthcare Limited IPO will be finalized on Feb 27, 2024. GPT Healthcare Limited IPO will be listed on BSE, NSE, with a tentative listing date fixed as Feb 29, 2024. The company shall list its equity shares on the BSE, NSE. Link Intime India Private Ltd is the registrar of the issue.

Retail investors can bid for a minimum of 80 shares, extendable to 14,880. S-HNIs will be able to bid for 1120 shares at ₹2,08,320, while B-HNIs can also apply for a bid of 5440 shares at ₹10,11,840. The book-running lead manager for the IPO is/are Jm Financial Limited.

The total issue ₹525.14 crore, comprising a fresh issue of 21,50,537 shares ₹40 crore and having Offer for Sale (OFS) of 2,60,82,786 shares to mop up ₹485.14 crore.

The GPT Healthcare Limited IPO sets its price band at 177-186 for each share. A single application for GPT Healthcare Limited IPO must contain at least 80 shares. Sentiment investors need to invest a minimum of 80 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,880 In order to participate in the sNII, investors must purchase at least 14 lots of 1120 shares for ₹2,08,320, while the bNII requires 68 lots of 5440 shares for an investment of ₹10,11,840.

Read More
GPT Healthcare Limited IPO Subscription Analysis And Details
Retail
2.44x
QIB
17.30x
NII
11.02x
bNII
11.98x
sNII
9.09x
Total
8.52x
As on QIB NII
bNII   sNII
Retail Total
Shares Offered / Reserved 5,646,665 4,234,999
2,823,333    1,411,667
9,881,663 19,763,327
Day 1 22-02-24 05:00 PM
0.00 x 0.18
0.14 x   0.25 x
0.66 x 0.37 x
Day 2 23-02-24 05:00 PM
0.19 x 0.79
0.69 x   0.99 x
1.25 x 0.85 x
Day 3 26-02-24 05:00 PM
17.30 x 11.02
11.98 x   9.09 x
2.44 x 8.52 x

Total No of Applications
258,361
Subscription on the basis of Applications
2.09
GPT Healthcare Limited Valuations
EPS Pre IPO ₹4.88/-
EPS Post IPO ₹/-
P/E Pre IPO 38.1
P/E Post IPO 32.49
ROE 23.59%
ROCE 26.09%
Debt/Equity 0.39
RoNW 23.77%
Price to Book Value 9.06
GPT Healthcare Limited Company Financials
In Crs.
In Cr.
31-Mar-23 31-Mar-22 31-Mar-21
Assets 326.76 323.22 317.21
Revenue 366.73 342.40 248.86
Profit After Tax 39.01 41.66 21.09
Net Worth 164.14 156.96 132.68
Reserves & Surplus 85.46 78.28 75.96
Total Borrowing 64.67 95.52 122.93
About GPT Healthcare Limited Company

GPT Healthcare Limited operates a chain of mid-sized, multi-specialty, full-service hospitals in Eastern India under the ILS Hospitals brand, providing integrated healthcare services focusing on secondary and tertiary care.

Based in Kolkata, West Bengal, the company offers a range of healthcare services in over 35 specialties and super-specialties, including internal medicine and diabetology, nephrology (including kidney transplant), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. It also offers integrated diagnostic services and pharmacies.

GPT Healthcare's hospitals are located in four cities, namely
Salt Lake, Kolkata (West Bengal) with a capacity of 85 beds, including 17 beds in various ICUs and HDUs (as of June 30,2023)
Agartala (Tripura) with a capacity of 205 beds (as of June 30,2023), including 66 beds in various ICUs and HDUs
Dum Dum, Kolkata (West Bengal) with a capacity of 155 beds, including 53 beds in various ICUs and HDUs as of June 30,2023
Howrah (West Bengal) with a capacity of 116 beds, including 43 beds in various ICUs and HDUs, as of June 30, 2023.

As at June 30,2023, the company operates four multidisciplinary hospitals with a total capacity of 561 beds, offering a comprehensive range of healthcare services in over 35 specialties and super-specialties.

As at June 30,2023, the company had 1,855 employees,85 full-time consultants, and 465 visiting consultants.

Read More
GPT Healthcare Limited - Promoter(s)

GPT Sons Private Limited

Dwarika Prasad Tantia

Dr. Om Tantia

Shree Gopal Tantia

Pre Issue Share Holding : 67.34%

Post Issue Share Holding : 65.57%

GPT Healthcare Limited IPO - Issue Objectives
1

Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company from banks and financial institutions

2

General corporate purposes.

GPT Healthcare Limited IPO - Anchor Investors

GPT Healthcare raises Rs 157.54 crore from anchor investors ahead of IPO.

Marquee foreign and domestic institutional investors invested in the company via anchor book included Societe Generale, Kotak Mutal Fund, Axis Mutual Fund, Bandhan Duro One Investments, Copthall Mauritius, Kotal Mutual Fund, Aditya Birla Life Insurance, LC Pharos Multi Strategy Fund, and DE Shaw Valence International.

GPT Healthcare Limited IPO - Peers Comparison
Company Name EPS (Basic) EPS (Diluted) NAV (per share) (Rs) P/E (x) RoNW (%) P/BV Ratio Financial statements
GPT Healthcare Limited 4.88 4.88 20.54 38.1 23.77 N/A Consolidated
Global Health Limited 12.58 12.57 89.65 90.29 13.56 8.67 Consolidated
Krishna Institute Of Medical Sciences Limited 42.03 42.03 206.47 49.51 20.35 9.34 Consolidated
Jupiter Life Line Hospitals Ltd 13.95 12.95 64.7 81.73 19.94 16.38 Consolidated
Yatharth Hospital & Trauma Care Services Limited 10.09 10.09 27.84 37.66 36.06 14.5 Consolidated
Kovai Medical Center & Hospital Ltd. 105.8 105.8 656.65 29.93 16.11 N/A Consolidated
Shalby Ltd 6.31 6.27 85.54 49.01 7.33 3.22 Consolidated

Notes:

  1. The P/E Ratio has been computed based on the closing market price of equity shares on October 13, 2023, divided by the Diluted EPS.
  2. Basic EPS and Diluted EPS refer to the Basic EPS and Diluted EPS sourced from the financial statements of the respective company.
  3. RoNW is computed as net profit after tax attributable to owners of the holding company divided by net-worth excluding non-controlling interest.
  4. Net worth is the aggregate value of the paid-up share capital and all reserves created out of the profits, securities premium account, and debit or credit balance of profit and loss account, after deducting the aggregate value of the accumulated losses, deferred expenditure, and miscellaneous expenditure not written off, as per the restated balance sheet, but does not include reserves created out of revaluation of assets, write-back of depreciation, and amalgamation.
  5. NAV per share is computed as net worth divided by the number of equity shares outstanding.
Contact Details

GPT Healthcare Limited

GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700106

+ (91) 33 4050 7000

ghl.cosec@gptgroup.co.in

https://www.gptgroup.co.in/gpt-healthcare/

Registrar Contact Details